Kansas City Cancer Center

Lenexa, Kansas 66214

0 studies enrolling now · 1 studies all time

What they study most

Cutaneous T-Cell Lymphoma, Non-Hodgkin's Lymphoma, Peripheral T-Cell Lymphoma

Studies at this site

• A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas — Stopped early